XERS
Xeris Biopharma Holdings Inc.
Company Overview
| Mkt Cap | $1.49B | Price | $9.70 |
| Volume | 1.93M | Change | -0.10% |
| P/E Ratio | -27.2 | Open | $9.76 |
| Revenue | $203.1M | Prev Close | $9.71 |
| Net Income | $-54.8M | 52W Range | $2.82 - $10.03 |
| Div Yield | N/A | Target | $9.00 |
| Overall | 54 | Value | 20 |
| Quality | 63 | Technical | 81 |
No chart data available
Stock Overview
Updated DailyXeris Biopharma Holdings Inc. (XERS) is a leading Healthcare company in the Biotechnology industry, currently trading at $9.70 with a market capitalization of $1.49 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows XERS with a volume of 1.93 million shares. The stock opened up 0.51% from yesterday's close of $9.71. Current analyst estimates project earnings of $-0.01 per share for this year, with next year targeting $0.31.
XERS demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for XERS include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -7.2%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 02:53 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XERS | $9.70 | -0.1% | 1.93M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Xeris Biopharma Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW